Cargando…

Use of the Common Marmoset to Study Burkholderia mallei Infection

Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelesijevic, Tomislav, Zimmerman, Shawn M., Harvey, Stephen B., Mead, Daniel G., Shaffer, Teresa L., Estes, D. Mark, Michel, Frank, Quinn, Frederick D., Hogan, Robert J., Lafontaine, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393281/
https://www.ncbi.nlm.nih.gov/pubmed/25860021
http://dx.doi.org/10.1371/journal.pone.0124181
_version_ 1782366142011015168
author Jelesijevic, Tomislav
Zimmerman, Shawn M.
Harvey, Stephen B.
Mead, Daniel G.
Shaffer, Teresa L.
Estes, D. Mark
Michel, Frank
Quinn, Frederick D.
Hogan, Robert J.
Lafontaine, Eric R.
author_facet Jelesijevic, Tomislav
Zimmerman, Shawn M.
Harvey, Stephen B.
Mead, Daniel G.
Shaffer, Teresa L.
Estes, D. Mark
Michel, Frank
Quinn, Frederick D.
Hogan, Robert J.
Lafontaine, Eric R.
author_sort Jelesijevic, Tomislav
collection PubMed
description Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. mallei and there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3–4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei.
format Online
Article
Text
id pubmed-4393281
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43932812015-04-21 Use of the Common Marmoset to Study Burkholderia mallei Infection Jelesijevic, Tomislav Zimmerman, Shawn M. Harvey, Stephen B. Mead, Daniel G. Shaffer, Teresa L. Estes, D. Mark Michel, Frank Quinn, Frederick D. Hogan, Robert J. Lafontaine, Eric R. PLoS One Research Article Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. mallei and there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3–4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei. Public Library of Science 2015-04-10 /pmc/articles/PMC4393281/ /pubmed/25860021 http://dx.doi.org/10.1371/journal.pone.0124181 Text en © 2015 Jelesijevic et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jelesijevic, Tomislav
Zimmerman, Shawn M.
Harvey, Stephen B.
Mead, Daniel G.
Shaffer, Teresa L.
Estes, D. Mark
Michel, Frank
Quinn, Frederick D.
Hogan, Robert J.
Lafontaine, Eric R.
Use of the Common Marmoset to Study Burkholderia mallei Infection
title Use of the Common Marmoset to Study Burkholderia mallei Infection
title_full Use of the Common Marmoset to Study Burkholderia mallei Infection
title_fullStr Use of the Common Marmoset to Study Burkholderia mallei Infection
title_full_unstemmed Use of the Common Marmoset to Study Burkholderia mallei Infection
title_short Use of the Common Marmoset to Study Burkholderia mallei Infection
title_sort use of the common marmoset to study burkholderia mallei infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393281/
https://www.ncbi.nlm.nih.gov/pubmed/25860021
http://dx.doi.org/10.1371/journal.pone.0124181
work_keys_str_mv AT jelesijevictomislav useofthecommonmarmosettostudyburkholderiamalleiinfection
AT zimmermanshawnm useofthecommonmarmosettostudyburkholderiamalleiinfection
AT harveystephenb useofthecommonmarmosettostudyburkholderiamalleiinfection
AT meaddanielg useofthecommonmarmosettostudyburkholderiamalleiinfection
AT shafferteresal useofthecommonmarmosettostudyburkholderiamalleiinfection
AT estesdmark useofthecommonmarmosettostudyburkholderiamalleiinfection
AT michelfrank useofthecommonmarmosettostudyburkholderiamalleiinfection
AT quinnfrederickd useofthecommonmarmosettostudyburkholderiamalleiinfection
AT hoganrobertj useofthecommonmarmosettostudyburkholderiamalleiinfection
AT lafontaineericr useofthecommonmarmosettostudyburkholderiamalleiinfection